These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics. KRUSE W. Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637 [No Abstract] [Full Text] [Related]
10. Combined tranlcypromine and trifluoperazine therapy in general medicine. LEWIS RA. Can Psychiatr Assoc J; 1962 Dec; 7(Suppl)():74-6. PubMed ID: 14464901 [No Abstract] [Full Text] [Related]
11. The use of stelazine and parnate in chronic, withdrawn patients. VOGT AH. Am J Psychiatry; 1961 Sep; 118():256-7. PubMed ID: 13781857 [No Abstract] [Full Text] [Related]
12. Parstelin in anxiety states and depression. HEMPHILL RE, FOSTER AR. J Coll Gen Pract; 1962 May; 5(2):238-45. PubMed ID: 13906375 [No Abstract] [Full Text] [Related]
17. A clinical trial of an antidepressant, tranylcy-promine ("Parnate"). KINGSTON WR. Med J Aust; 1962 Jun 30; 49(1)():1011-2. PubMed ID: 14456153 [No Abstract] [Full Text] [Related]
18. [BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY OF MONOAMINE OXIDASE INHIBITORS: THE ASSOCIATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE IN THE THERAPY OF DEPRESSIVE SYNDROMES]. GRATTAROLA FR, ROSSO G, ROVERA GG. Clin Ter; 1963 Sep 15; 26():406-30. PubMed ID: 14091908 [No Abstract] [Full Text] [Related]